MUSE Cells Explained: Dr. Joy Kong on Anti-Aging and Stem Cell Therapy
Are MUSE cells the next big shift in regenerative medicine, or are they another stem cell buzzword wrapped in shiny packaging? That is the honest question patients should ask before getting excited. In a video from The Dr. Joy Kong Podcast titled “Anti-Aging, Zero Rejection, and the Future of Stem Cell Therapy,” Dr. Joy Kong […]
REPROCELL Wins MSCRF Award to Advance Hypoimmune iPSC Platforms
What happens when cell therapy needs to reach more patients, but manufacturing and immune compatibility still act like locked gates? That is the tension behind REPROCELL’s new Commercialization Award from the Maryland Stem Cell Research Fund, which will support work on hypoimmune iPSC platforms for clinical applications.1 This is not a flashy promise about a […]
NOVAKnee Program Names Made Scientific as Manufacturer for Living Biologic Knee Replacement
Made Scientific will manufacture Columbia’s NOVAKnee implants for a Phase 1 trial expected in 2028 under FDA oversight.
3D-Bioprinted Stem Cell Scaffolds for Bone Repair: What Science Shows So Far
New preclinical research explores 3D-bioprinted stem cell scaffolds for bone repair, but it is not clinic-ready yet.
Family-Donor Stem Cells for Epidermolysis Bullosa: Early Trial Results Explained
A pediatric trial reported family-donor MSCs were safe in RDEB and improved symptoms. Here is what the evidence means.
Stem Cells for Stroke Recovery: New Study Shows Brain Repair in Mice
Preclinical research shows iPSC-derived neural progenitor cells helped repair stroke injury in mice. Here is what patients should know.
iPSC-Derived Immune Cells From a New Bioreactor: Why 40 Million Macrophages a Week Matters
A new bioreactor method may produce 40 million iPSC-derived macrophages weekly for research and therapy development.
Cellular Intelligence Secures Novo Nordisk Parkinson’s Cell Therapy Rights
What happens when a clinical-stage Parkinson’s cell therapy program changes hands? What should patients, families, and the regenerative medicine field watch next? Cellular Intelligence announced that it has acquired global rights to Novo Nordisk’s clinical-stage cell therapy program for Parkinson’s disease.1 The agreement places a first-in-human Phase 1/2 program under an AI-native TechBio company that […]
How to Vet Stem Cell Therapy Providers: Red Flags, Questions, and Proof
If you are considering stem cell therapy, you are probably wondering how to vet stem cell therapy providers. Many patients feel overwhelmed and uncertain about which clinics are trustworthy. You might be asking yourself: Is this treatment safe? Is the clinic following government regulations? What questions should I ask before committing? These concerns are valid […]
Post-Procedure Care After Stem Cell Therapy: What Patients Should Do Next
Many patients ask what they should do after stem cell therapy to ensure the best possible outcome. Questions like “How do I care for myself after the procedure?” or “What activities should I avoid?” are common. Understanding post-procedure care after stem cell therapy is crucial for supporting your body’s healing process and avoiding complications. Stem […]